Arkolith/Insider Trading/ALDX/Form 4

Brady Todd C

President and CEO, DirectorAldeyra Therapeutics, Inc. (ALDX) · full profile →Form 4 · filed Mar 12, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$580K
Net Open-Market Flow
-$580K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 12, 2024Sell(S)85K$3.05$260K1.5M
Mar 11, 2024Sell(S)98K$3.27$320K1.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 9, 2024Grant(A)1.1M—$01.1M

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-030309) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML